Table 3.
Clinicopathological characteristics according to EGFR mutation status
EGFR positive | EGFR negative | P value | |
---|---|---|---|
N |
119 |
98 |
|
Age |
63.50 ± 9.11 |
62.68 ± 11.35 |
0.559 |
Sex (M:F) |
43:76 |
55:43 |
0.003 |
PYR |
5.805 ± 14.426 |
14.031 ± 19.193 |
<0.001 |
Pathologic stage |
117* |
95* |
0.199 |
0 |
6 |
9 |
|
IA |
87 |
57 |
|
IB |
18 |
18 |
|
IIA |
1 |
5 |
|
IIB |
2 |
0 |
|
IIIA |
3 |
5 |
|
IIIB |
0 |
1 |
|
Nodal involvement |
5 |
10 |
0.106 |
Histologic invasiveness |
118† |
98 |
0.600 |
AIS |
6 |
9 |
|
MIA |
11 |
5 |
|
IA |
101 |
84 |
|
Maximal diameter |
22.387 ± 9.876 |
22.376 ± 12.052 |
0.507 |
Solid diameter |
11.133 ± 11.229 |
12.559 ± 11.257 |
0.353 |
TDR | 0.702 ± 0.295 | 0.687 ± 0.290 | 0.720 |
*Data for pathologic stage were unavailable for 2 EGFR positive and 3 EGFR negative patients.
†Data for histologic invasiveness were unavailable for 1 patient.